Marie von Lilienfeld‐Toal

Author

Also Known As

ECIL 9, EHA Infectious Disease Scientific Working Group, J. J. Vehreschild, Lilienfeld-Toal M., M Von Lilienfeld-Toal, M von Lilienfeld-Toal, M. Lilienfeld-Toal, M. v. Lilienfeld-Toal, M. von Lilienfeld-Toal, M. von Lilienfeld‐Toal

195

Publications

11.1K

Citations

H-Index

Concepts

All Affiliations

Jena University Hospital University Hospital Bonn Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)Heidelberg University Medizinische Hochschule Hannover

About

Marie von Lilienfeld‐Toal is an author at Jena University Hospital specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.2K
2	Health Sciences	7	7	450
3	Cell Biology	4	4	154
4	Public Health	3	3	78
5	Cellular Therapies	1	1	44

Marie von Lilienfeld‐Toal

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, New England Journal of Medicine	2013	1.6K
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten, New England Journal of Medicine	2009	818
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Blood	2011	672
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML Sabine Käyser, Konstanze Döhner, Jürgen Krauter, Blood	2010	479
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen, Journal of Clinical Oncology	2011	388
<i>TET2</i> Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group Verena I. Gaidzik, Peter Paschka, Daniela Späth, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaGeneticsPathologyTet2 MutEpigenetics	2012	182
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG) Peter Paschka, Juan Du, Richard F. Schlenk, Blood	2012	181
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka, Blood	2013	178
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies Sabine Käyser, Manuela Zucknick, Konstanze Döhner, Blood	2011	151
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein Marie von Lilienfeld‐Toal, Muriel Dietrich, Axel Glasmacher, European Journal of Clinical Microbiology & Infectious Diseases GranulocytePathogenesisImmunologyHematologyPathology	2004	146

Page 1